Relationships among CYP3A4 and CYP3A5 haplotypes, mRNA expression, CYP3A activity and atorvastatin response in hypercholesterolemic individuals (2010)
- Autores:
- Autores USP: HIRATA, MARIO HIROYUKI - FCF ; DOREA, EGIDIO LIMA - HU ; HIRATA, ROSARIO DOMINGUEZ CRESPO - FCF
- Unidades: FCF; HU
- Assuntos: HIPERCOLESTEROLEMIA; POLIMORFISMO
- Idioma: Inglês
- Imprenta:
- Local: Washington
- Data de publicação: 2010
- Fonte:
- Título do periódico: Clinical Chemistry
- Volume/Número/Paginação/Ano: v. 56, n. 6 suppl., p. A89-A90 res. B-117, 2010
- Nome do evento: American Association for Clinical Chemistry Annual Meeting/AACC
-
ABNT
WILLRICH, Maria Alice Vieira et al. Relationships among CYP3A4 and CYP3A5 haplotypes, mRNA expression, CYP3A activity and atorvastatin response in hypercholesterolemic individuals. Clinical Chemistry. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 14 maio 2024. , 2010 -
APA
Willrich, M. A. V., Genvigir, F. D. V., Rodrigues, A. C., Arazi, S. S., Oliveira, R., Hirata, M. H., et al. (2010). Relationships among CYP3A4 and CYP3A5 haplotypes, mRNA expression, CYP3A activity and atorvastatin response in hypercholesterolemic individuals. Clinical Chemistry. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. -
NLM
Willrich MAV, Genvigir FDV, Rodrigues AC, Arazi SS, Oliveira R, Hirata MH, Dórea EL, Hirata RDC. Relationships among CYP3A4 and CYP3A5 haplotypes, mRNA expression, CYP3A activity and atorvastatin response in hypercholesterolemic individuals. Clinical Chemistry. 2010 ; 56( 6 suppl.): A89-A90 res. B-117.[citado 2024 maio 14 ] -
Vancouver
Willrich MAV, Genvigir FDV, Rodrigues AC, Arazi SS, Oliveira R, Hirata MH, Dórea EL, Hirata RDC. Relationships among CYP3A4 and CYP3A5 haplotypes, mRNA expression, CYP3A activity and atorvastatin response in hypercholesterolemic individuals. Clinical Chemistry. 2010 ; 56( 6 suppl.): A89-A90 res. B-117.[citado 2024 maio 14 ] - Differentiation of african components of ancestry to stratify groups in a case-control study of a brazilian urban population
- Genetic variants in genes related to lipid metabolism and atherosclerosis, dyslipidemia and atorvastatin response
- Apolipoprotein E mRNA expression in mononuclear cells from normolipidemic and hypercholesterolemic individuals treated with atorvastatin
- Expression of inflammatory response genes in pbmc from type 2 diabetes individuals treated with simvastatin and ezetimibe
- Leptin receptor gene polymorphisms are associated with adiposity and metabolic alterations in Brazilian individuals
- CYP3A4 and CYP3A5 mRNA expression in hypercholesterolemic individuals under hypolipemiant therapy
- Influence of SCARB1 polymorphisms on serum lipids of hypercholesterolemic individuals treated with atorvastatin
- Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression
- The contribution of genetic polymorphisms in 60 candidate genes to variability in atorvastatin response
- CYP3A5*3A allele is associated with reduced lowering-lipid response to atorvastatin in individuals with hypercholesterolemia
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
